Home › Funds › Nantahala Capital Management, LLC › NBIX

Nantahala Capital Management, LLC position in NBIX

NEUROCRINE BIOSCIENCES INC · Health Care

Nantahala Capital Management, LLC reported holding 220,400 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$31.3M, representing 1.43% of its reported portfolio and ranking #19 among its reported holdings. Nantahala Capital Management, LLC has disclosed NBIX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)220.40K sh
Reported value held$31.26M
Portfolio Weight1.43%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nantahala Capital Management, LLC's NBIX position evolved

Nantahala Capital Management, LLC first disclosed a stake in NBIX in Q2 2026 at 200,000 shares (US$33.7M). Across 2 filings, Nantahala Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 220,400 shares valued at US$31.3M — an increase of 20,400 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 200.00K $33.71M New
Q3 2026 220.40K $31.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBIX and 13F data

NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 30 other funds we track also report a position in NBIX — the largest reported positions include Two Sigma Investments (US$349.9M), Renaissance Technologies (US$326.3M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBIX

All NBIX fund holders →

FAQ

How long has Nantahala Capital Management, LLC held NBIX?

Nantahala Capital Management, LLC has disclosed NBIX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Nantahala Capital Management, LLC's current position in NBIX?

As of Q3 2026, Nantahala Capital Management, LLC holds 220.40K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $31.26M, representing 1.43% of its reported portfolio and ranking #19.

Has Nantahala Capital Management, LLC been buying or selling NBIX?

In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC increased its position in NBIX.

Which other funds hold NBIX?

Other major institutional holders of NBIX include Two Sigma Investments, Renaissance Technologies, Vestal Point Capital, LP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.